查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球猴痘（Empox）診斷市場：按檢測、國家、產品、地點 - 包括執行顧問指南的市場分析和預測（2024-2028）
市場調查報告書
商品編碼
1537093

全球猴痘（Empox）診斷市場：按檢測、國家、產品、地點 - 包括執行顧問指南的市場分析和預測（2024-2028）

Monkeypox (MPOX) Diagnostics Global Markets by Assay, by Country, by Product, and by Place. With Executive and Consultant Guides and Market Analysis and Forecasts 2024 - 2028
出版日期: | 出版商: Howe Sound Research | 英文 312 Pages | 商品交期: 最快1-2個工作天內

價格

猴痘（Empox）被視為一種健康緊急情況。世界各國政府正準備進行廣泛的測試，以盡快發現這項威脅。體外診斷產業充滿機會。

本報告考察了全球猴痘（Empox）診斷市場，並提供了市場概述、分析趨勢、國家、產品、地點以及進入該市場的公司概況。

目錄

第1章 市場指南

第2章 介紹與市場定義

  • 猴痘診斷概述
  • 市場定義
  • 調查方法
  • 觀點：醫療保健和 IVD 產業

第3章 猴痘 - 當代科學

  • 什麼是猴痘？
  • 爆發
  • 感染
  • 徵兆和症狀
  • 診斷
  • 治療藥物
  • 猴痘和天花之間的關係

第4章 產業概論

  • 市場准入組織
    • 學術研究所
    • 診斷測試開發人員
    • 藥品和試劑供應商
    • 獨立的臨床實驗室
    • 公共國家/地區研究機構
    • 醫院實驗室
    • 臨床實驗室
    • 審計機構
    • 認證機構

第5章 市場趨勢

  • 生長促進因素
  • 抑制生長的因素
  • 診斷技術開發

第6章 猴痘診斷 - 最新趨勢

第7章 主要公司簡介

  • Abbott Laboratories
  • Aegis Science Corporation
  • Applied DNA Sciences
  • Beckman Coulter Diagnostics（Danaher）
  • Becton, Dickinson and Company
  • BGI Genomics Co. Ltd
  • BioFire Diagnostics（bioMerieux）
  • BioGX
  • bioMerieux Diagnostics
  • Bio-Rad Laboratories, Inc.
  • Cepheid（Danaher）
  • Cerstest Biotec
  • Flow Health
  • Laboratory Corporation of America
  • Mayo Clinic Laboratories
  • Novacyt
  • Proof Diagnostics
  • Qiagen
  • Quest Diagnostics
  • Roche Diagnostics
  • Siemens Healthineers
  • Sonic Healthcare
  • Sysmex
  • Thermo Fisher Scientific
  • Vela Diagnostics

第8章 全球猴痘診斷市場概述

  • 猴痘診斷 - 依國家的世界市場概覽
  • 全球猴痘診斷市場概況（依檢測）
  • 全球猴痘診斷市場概況（依產品）
  • 全球猴痘診斷市場概況（依地區）

第9章 猴痘診斷市場 - 依檢測

  • 猴痘診斷-PCR
  • 猴痘診斷-NGS
  • 猴痘診斷-免疫分析
  • 猴痘診斷-其他

第10章 全球猴痘診斷市場 - 依產品

  • 猴痘診斷-設備
  • 猴痘診斷-耗材
  • 猴痘診斷-軟體與服務

第11章 全球猴痘診斷市場 - 依地點

  • 猴痘診斷-醫院
  • 猴痘診斷-診所/POL
  • 猴痘診斷-其他

第12章 附錄

OVERVIEW:

Monkeypox is being declared a health emergency. Governments around the world are preparing to use widespread testing to get in front of this threat from the beginning. Opportunities abound for the In Vitro Diagnostic Industry.

The report forecasts the market size out to 2028. Growth is coming from the basic factors but the COVID Pandemic has changed to market landscape now and for the foreseeable future. Some players have already made their mark but disruptive diagnostic technology could change the playing field. Learn about this market including the issues and outlooks. The two key trends of Rapid Diagnostics and the Genomics Revolution are merging to create new diagnostic opportunities.

All report data is available in Excel format on request.

Table of Contents

1. Market Guides

  • 1.1. Situation Analysis
  • 1.2. Guide for Executives and Marketing Staff
  • 1.3. Guide for Investment Analysts and Management Consultants

2. Introduction and Market Definition

  • 2.1. An Overview of Monkeypox Diagnostics
    • 2.1.1. The 2022 Outbreak
  • 2.2. Market Definition
    • 2.2.1. Market Size
    • 2.2.2. Currency
    • 2.2.3. Years
    • 2.2.4. PCR
    • 2.2.5. NGS
    • 2.2.6. Immunoassay
    • 2.2.7. Rapid Diagnostics
    • 2.2.8. Limitations
  • 2.3. Methodology
    • 2.3.1. Methodology
    • 2.3.2. Sources
    • 2.3.3. Authors
  • 2.4. Perspective: Healthcare and the IVD Industry
    • 2.4.1. Global Healthcare Spending
    • 2.4.2. Spending on Diagnostics
    • 2.4.3. Important Role of Insurance for Diagnostics

3. Monkeypox - Current Science

  • 3.1. What is Monkeypox?
  • 3.2. Outbreaks
  • 3.3. Transmission
  • 3.4. Signs and symptoms
  • 3.5. Diagnosis
  • 3.6. Therapeutics
    • 3.6.1. Vaccination
    • 3.6.2. Prevention
      • 3.6.2.1. Reducing the risk of human-to-human transmission
      • 3.6.2.2. Reducing the risk of zoonotic transmission
  • 3.7. How monkeypox relates to smallpox

4. Industry Overview

  • 4.1. Players in a Dynamic Market
    • 4.1.1. Academic Research Lab
    • 4.1.2. Diagnostic Test Developer
    • 4.1.3. Pharmaceutical/Reagent Supplier
    • 4.1.4. Independent Testing Lab
    • 4.1.5. Public National/regional lab
    • 4.1.6. Hospital lab
    • 4.1.7. Physician Lab
    • 4.1.8. Audit Body
    • 4.1.9. Certification Body

5. Market Trends

  • 5.1. Factors Driving Growth
    • 5.1.1. Prevalence
    • 5.1.2. Surveillance
    • 5.1.3. Pandemic Wind Down
    • 5.1.4. Viral Zeitqeist
    • 5.1.5. Healthcare Spend
  • 5.2. Factors Limiting Growth
    • 5.2.1. The Cost Curve Shrinks the Market
    • 5.2.2. Transmission Outlook
    • 5.2.3. Adoption Lag and Cost Control
  • 5.3. Diagnostic Technology Development
    • 5.3.1. The Multiplex Opportunity
    • 5.3.2. Shifting Role of Physicians in Diagnosis
    • 5.3.3. Diagnostics Moves Out of the Lab
    • 5.3.4. Biomarkers and Algorithms
    • 5.3.5. Rapid Testing Changing Medical Practice
    • 5.3.6. Genome Role and Big Data

6. Mpox Diagnostics - Recent Developments

  • 6.1. Recent Developments - Importance and How to Use This Section
    • 6.1.1. Importance of These Developments
    • 6.1.2. How to Use This Section
  • 6.2. WHO Declares MPOX a Health Emergency
  • 6.3. Human monkeypox disease prediction
  • 6.4. Most Dangerous Monkeypox Virus Yet
  • 6.5. South Africa reports second mpox death
  • 6.6. New Strain of MPOX Raising Alarm
  • 6.7. Labcorp Receives EUA for Home Mpox Test
  • 6.8. Ultrasensitive single-step CRISPR detection of MPOX virus
  • 6.9. Many new mpox cases are in China
  • 6.10. U.S. to declare monkeypox a public health emergency
  • 6.11. BioGX Gets CE-IVD Mark for Multigene POC Test
  • 6.12. World Health Organization declares monkeypox a global emergency
  • 6.13. Quest Begins Offering Internally Developed Monkeypox Test
  • 6.14. CDC, Abbott, Roche, BioMerieux Get FDA 510(k) Clearances
  • 6.15. Commercial, Academic Labs Ramp Up Monkeypox Testing
  • 6.16. Becton Dickinson, CerTest Biotec Collaborate on Monkeypox MDx
  • 6.17. Monkeypox Virus Sequenced

7. Profiles of Key Companies

  • 7.1. Abbott Laboratories
  • 7.2. Aegis Science Corporation
  • 7.3. Applied DNA Sciences
  • 7.4. Beckman Coulter Diagnostics (Danaher)
  • 7.5. Becton, Dickinson and Company
  • 7.6. BGI Genomics Co. Ltd
  • 7.7. BioFire Diagnostics (bioMerieux)
  • 7.8. BioGX
  • 7.9. bioMerieux Diagnostics
  • 7.10. Bio-Rad Laboratories, Inc.
  • 7.11. Cepheid (Danaher)
  • 7.12. Cerstest Biotec
  • 7.13. Flow Health
  • 7.14. Laboratory Corporation of America
  • 7.15. Mayo Clinic Laboratories
  • 7.16. Novacyt
  • 7.17. Proof Diagnostics
  • 7.18. Qiagen
  • 7.19. Quest Diagnostics
  • 7.20. Roche Diagnostics
  • 7.21. Siemens Healthineers
  • 7.22. Sonic Healthcare
  • 7.23. Sysmex
  • 7.24. Thermo Fisher Scientific
  • 7.25. Vela Diagnostics

8. Monkeypox Global Diagnostic Markets Overview

  • 8.1. Monkeypox Diagnostics - Global Market Overview by Country
    • 8.1.1. Table - Global Market by Country
    • 8.1.2. Chart - Global Market by Country
  • 8.2. Global Monkeypox Diagnostics Markets Overview by Assay
    • 8.2.1. Table - Global Market by Assay
    • 8.2.2. Chart - Global Market by Assay - Segments Growth
    • 8.2.3. Chart - Global Market by Assay - Share by Year
    • 8.2.4. Chart - Global Market by Assay
    • 8.2.5. Chart - Global Market by Assay - Base Year
    • 8.2.6. Chart - Global Market by Assay - Final Year
  • 8.3. Global Monkeypox Diagnostics Markets Overview by Product
    • 8.3.1. Table - Global Market by Product
    • 8.3.2. Chart - Global Market by Product - Segments Growth
    • 8.3.3. Chart - Global Market by Product - Share by Year
    • 8.3.4. Chart - Global Market by Product
    • 8.3.5. Chart - Global Market by Product - Base Year
    • 8.3.6. Chart - Global Market by Product - Final Year
  • 8.4. Global Monkeypox Diagnostics Markets Overview by Place
    • 8.4.1. Table - Global Market by Place
    • 8.4.2. Chart - Global Market by Place - Segments Growth
    • 8.4.3. Chart - Global Market by Place - Share by Year
    • 8.4.4. Chart - Global Market by Place
    • 8.4.5. Chart - Global Market by Place - Base Year
    • 8.4.6. Chart - Global Market by Place - Final Year

9. Monkeypox Diagnostic Market - by Assay

  • 9.1. Monkeypox Diagnostic - PCR
    • 9.1.1. Table Monkeypox Diagnostic PCR - by Country
    • 9.1.2. Chart - Monkeypox Diagnostic PCR Growth
  • 9.2. Monkeypox Diagnostic - NGS
    • 9.2.1. Table Monkeypox Diagnostic NGS - by Country
    • 9.2.2. Chart - Monkeypox Diagnostic - NGS Growth
  • 9.3. Monkeypox Diagnostic - Immunoassay
    • 9.3.1. Table Monkeypox Immunoassay - by Country
    • 9.3.2. Chart - Monkeypox Diagnostic - Immunoassay Growth
  • 9.4. Monkeypox Diagnostic - Other Assay
    • 9.4.1. Table Monkeypox Diagnostic Other Assay - by Country
    • 9.4.2. Chart - Monkeypox Diagnostic - Other Assay Growth

10. Global Monkeypox Diagnostics Markets - By Product

  • 10.1. Monkeypox Diagnostic - Instrumentation
    • 10.1.1. Table Monkeypox Diagnostic Instrumentation - by Country
    • 10.1.2. Chart - Monkeypox Diagnostic Instrumentation Growth
  • 10.2. Monkeypox Diagnostic - Consumables
    • 10.2.1. Table Monkeypox Diagnostic Consumables - by Country
    • 10.2.2. Chart - Monkeypox Diagnostic Consumables
  • 10.3. Monkeypox Diagnostic - Software & Service
    • 10.3.1. Table Monkeypox Diagnostic Software & Service - by Country
    • 10.3.2. Chart - Monkeypox Diagnostic - Software & Service Growth

11. Global Monkeypox Diagnostics Markets - By Place

  • 11.1. Monkeypox Diagnostic - Hospital
    • 11.1.1. Table Monkeypox Diagnostic Hospital - by Country
    • 11.1.2. Chart - Monkeypox Diagnostic Hospital Growth
  • 11.2. Monkeypox Diagnostic - Clinic/POL
    • 11.2.1. Table Monkeypox Diagnostic Clinic/POL - by Country
    • 11.2.2. Chart - Monkeypox Diagnostic Clinic/POL Growth
  • 11.3. Monkeypox Diagnostic - Other Place
    • 11.3.1. Table Monkeypox Diagnostic Other Place - by Country
    • 11.3.2. Chart - Monkeypox Diagnostic Other Place

12. Appendices

  • 12.1. Commercially Available Monkeypox Tests
  • 12.2. United States Medicare System: Clinical Laboratory Fees Schedule

Table of Tables

  • Table 1: Market Players by Type
  • Table 2: Five Factors Driving Growth
  • Table 3: Factors Limiting Growth
  • Table 4: Global Monkeypox Diagnostics Market by Country/Region
  • Table 5: Global Market by Assay
  • Table 6: Global Market by Product
  • Table 7: Global Market by Place
  • Table 8: Monkeypox Diagnostic PCR by Country
  • Table 9: Monkeypox Diagnostic NGS by Country
  • Table 10: Monkeypox Diagnostic Immunoassay by Country
  • Table 11: Monkeypox Diagnostic Other Assay by Country
  • Table 12: Monkeypox Diagnostic Instrumentation by Country
  • Table 13: Monkeypox Diagnostic Consumables by Country
  • Table 14: Monkeypox Diagnostic Software & Service by Country
  • Table 15: Monkeypox Diagnostic Hospital by Country
  • Table 16: Monkeypox Diagnostic Clinic/POL by Country
  • Table 17: Monkeypox Diagnostic Other Place by Country
  • Table 18: Commercially Available Monkeypox Tests
  • Table 19: Clinical Lab Fee Schedule

Table of Figures

  • Figure 1: Recent Global Cases
  • Figure 2: Total Cases Outside Endemic Africa
  • Figure 3: World Prevalence map
  • Figure 4: Growth in Health Care Spending Developing World
  • Figure 5: Comparing The New Diagnostics and Traditional Testing
  • Figure 6: Global Market Share Chart
  • Figure 7: Monkeypox Diagnostics Market Segment Shift Base vs Final year
  • Figure 8: Monkeypox Diagnostics Market by Assay Base Year
  • Figure 9: Monkeypox Diagnostics Market by Assay Final Year
  • Figure 10: Monkeypox Diagnostics Market Segment Shift Base vs Final year
  • Figure 11: Monkeypox Diagnostics Market by Product Base Year
  • Figure 12: Monkeypox Diagnostics Market by Product Final Year
  • Figure 13: Monkeypox Diagnostics Market Segment Shift Base vs Final year
  • Figure 14: Monkeypox Diagnostics Market by Place Base Year
  • Figure 15: Monkeypox Diagnostics Market by Place Final Year
  • Figure 16: Monkeypox Diagnostics Syndromic POC Panel Growth
  • Figure 17: Monkeypox Diagnostic NGS Growth
  • Figure 18: Monkeypox Diagnostic Immunoassay Growth
  • Figure 19: Monkeypox Diagnostic Other Assay Growth
  • Figure 20: Monkeypox Diagnostic Instrumentation Growth
  • Figure 21: Monkeypox Diagnostics Consumables
  • Figure 22: Monkeypox Diagnostic Software & Service Growth
  • Figure 23: Monkeypox Diagnostic GastroIntestinal Growth
  • Figure 24: Monkeypox Diagnostic Clinic/POL Growth
  • Figure 25: Monkeypox Diagnostics Other Place